title: Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.
abstract: Heart failure is one of the most common chronic medical conditions in the developed world. It is characterized by neurohormonal activation of multiple systems that can lead to clinical deterioration and significant morbidity and mortality. In this regard, hyponatremia is due to inappropriate and continued vasopressin activity despite hypoosmolality and volume overload. Hyponatremia is also due to diuretic use in an attempt to manage volume overload. When hyponatremia occurs, it is a marker of heart failure severity and identifies patients with increased mortality. The recent introduction of specific vasopressin-receptor antagonists offers a targeted pharmacological approach to these pathophysiological derangements. Thus far, clinical trials with vasopressin-receptor antagonists have demonstrated an increase in free-water excretion, improvement in serum sodium, modest improvements in dyspnea but no improvement in mortality. Continued clinical trials with these agents are needed to determine their specific role in the treatment of both chronic and decompensated heart failure.
authors: Divsions of Nephrology and Critical Care, University of Alberta, Edmonton, AB, Canada T6G 2G3.
authors: Adam
authors: A
authors: Romanovsky
authors: Sean
authors: S
authors: Bagshaw
authors: Mitchell H
authors: MH
authors: Rosner
references: J Am Soc Nephrol. 1999 Mar;10(3):647-63
references: 10073616
references: N Engl J Med. 2003 Apr 3;348(14):1309-21
references: 12668699
references: Arch Intern Med. 2006 Apr 10;166(7):781-6
references: 16606816
references: Eur Heart J. 2007 Apr;28(8):980-8
references: 17309900
references: Circulation. 2005 May 17;111(19):2454-60
references: 15867182
references: Circulation. 2001 Nov 13;104(20):2417-23
references: 11705818
references: Clin Endocrinol Metab. 1983 Nov;12(3):747-70
references: 6368055
references: Clin Pharmacokinet. 1996 Mar;30(3):229-49
references: 8882303
references: Arch Intern Med. 2007 Oct 8;167(18):1998-2005
references: 17923601
references: Circulation. 1986 Feb;73(2):257-67
references: 3002660
references: Mayo Clin Proc. 2010 Feb;85(2):180-95
references: 20118395
references: Chest. 1993 Feb;103(2):601-6
references: 8432162
references: Am J Nephrol. 2007;27(5):447-57
references: 17664863
references: N Engl J Med. 1992 Sep 3;327(10):685-91
references: 1463530
references: J Clin Endocrinol Metab. 1984 Nov;59(5):924-30
references: 6384261
references: Clin Endocrinol (Oxf). 2003 Jan;58(1):1-17
references: 12519405
references: Am J Med. 1987 Jun;82(6):1213-9
references: 3300305
references: Expert Opin Drug Saf. 2010 Mar;9(2):259-73
references: 20095916
references: JAMA. 2007 Mar 28;297(12):1332-43
references: 17384438
references: Circulation. 2008 Jan 29;117(4):e25-146
references: 18086926
references: Ann Intern Med. 1985 Jul;103(1):1-6
references: 2860833
references: Am J Cardiol. 2007 Jan 22;99(2A):4A-23A
references: 17239703
references: N Engl J Med. 1991 Aug 1;325(5):293-302
references: 2057034
references: N Engl J Med. 1987 Jun 4;316(23):1429-35
references: 2883575
references: N Engl J Med. 1999 Sep 2;341(10):709-17
references: 10471456
references: Am Heart J. 2003 Jul;146(1):9-18
references: 12851603
references: Kidney Int. 2010 Jul;78(2):160-9
references: 20445498
references: Am J Physiol Renal Physiol. 2010 Mar;298(3):F502-9
references: 20007345
references: Circulation. 1990 Nov;82(5):1724-9
references: 2146040
references: Eur Heart J. 2006 Jun;27(12):1431-9
references: 16709595
references: J Am Coll Cardiol. 2006 Apr 18;47(8):1615-21
references: 16630999
references: Cleve Clin J Med. 2006 Jun;73 Suppl 2:S2-7; discussion S30-3
references: 16786906
references: Horm Metab Res. 2010 Jan;42(1):56-60
references: 19672816
references: J Pharmacol Exp Ther. 2000 Jan;292(1):288-94
references: 10604960
references: Am J Med. 1999 Jan;106(1):90-6
references: 10320123
references: Circulation. 2003 Jun 3;107(21):2690-6
references: 12742979
references: Am J Physiol. 1985 Mar;248(3 Pt 2):H396-402
references: 3156513
references: JAMA. 2004 Apr 28;291(16):1963-71
references: 15113814
references: Am J Cardiol. 1986 Aug 1;58(3):295-9
references: 3739918
references: J Card Fail. 2008 Oct;14(8):641-7
references: 18926434
references: JAMA. 2007 Mar 28;297(12):1319-31
references: 17384437
references: Am J Physiol. 1998 Jul;275(1):H176-82
references: 9688911
references: Am J Cardiol. 2005 Dec 19;96(12A):19L-23L
references: 16399089
references: Clin Cardiol. 2010 Jun;33(6):322-9
references: 20556801
references: Eur J Heart Fail. 2007 Oct;9(10):1064-9
references: 17719273
references: J Clin Invest. 1973 Dec;52(12):3212-9
references: 4750450
references: J Pharmacol Exp Ther. 1995 Feb;272(2):546-51
references: 7853167